Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2015

View Archived Issues

Preclinical results presented for a BAX activator molecule

Sunitinib shows antitumor activity in thyroid cancer patients

Prozymex reports development of DPP-I inhibitors

University of Texas System patent describes new engineered primate L-methioninase

Peloton Therapeutics presents HIF-2alpha inhibitors

Dako and Amgen expand companion diagnostics collaboration

Scientists design novel PHEO mouse model

Imaging agent 64Cu-DOTA-AE-105 tested in prostate cancer patients

Further clinical data reported for preregistered hypercholesterolemia treatment evolocumab

La Jolla initiates phase III trial of LJPC-501 for catecholamine-resistant hypotension

ThromboGenics reports topline data on Jetrea in symptomatic vitreomacular adhesion

Nippon Shinyaku to continue clinical development of NS-065 for DMD

GenVec and TheraBiologics to develop cancer therapies based on neural stem cell technology

New S1P1 antagonist presented for the treatment of autoimmune disease

Gilead's sofosbuvir approved in Japan for genotype 2 HCV infection

Regulus receives European orphan medicinal product designation for RG-012

FDA approves Regeneron's aflibercept for diabetic retinopathy in diabetic macular edema

Quadracel approved in U.S. for vaccination of children aged 4-6 years

EUSA Pharma regains independence from Jazz Pharmaceuticals

Università degli Studi di Padova describes use of SERPINB3 for SLE

Therapure Innovations receives FDA approval to conduct phase I trial of TBI-302

Calitor Sciences discloses ALK and/or HGFR inhibitors

Sun Pharmaceutical completes acquisition of Ranbaxy from Daiichi Sankyo

FDA approves Emergent BioSolutions' Anthrasil for treatment of inhalational anthrax

MBX-8025 gains U.S. orphan drug status for homozygous familial hypercholesterolemia

Lilly's Cyramza obtains approval for gastric cancer in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...